Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium.

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...

Catheter Ablation Devices for Atrial Fibrillation Market 2035, Driven by advanced devices, better clinical outcomes, and rising regulatory approvals.

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate ...

A novel diffusion model generates synthetic atrial fibrosis images to augment data for deep learning, improving prediction of ...

Boston Scientific (BSX) announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Jackson-Madison County General Hospital now offers a new therapy to treat patients with advanced atrial fibrillation, who ...

Atrial fibrillation is frequently treated with ablation—a procedure where doctors create small, controlled scars to block erratic electrical signals. However, success rates vary considerably ...